secwatch / observer
8-K filed December 5, 2024, 6:59 PM ET ticker WINT CIK 0000946486
regulatory confidence high sentiment negative materiality 0.85

WINDTREE THERAPEUTICS INC /DE/ (WINT): Nasdaq/NYSE listing notice — Windtree receives Nasdaq delisting notices for board independence and bid price deficiencies

WINDTREE THERAPEUTICS INC /DE/

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

WINDTREE THERAPEUTICS INC /DE/ received a nasdaq deficiency notice notice regarding board independence (rules 5605(b)(1), 5605(c)(2)(A)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
board independence
Rules
5605(b)(1), 5605(c)(2)(A)
Exact text from the filing
December 4, 2024, the Company received a notice (the “ Audit Committee & Board Independence Notice ”) from the Nasdaq Listing Qualifications Department (the “ Staff ”) indicating that the Company no longer complies with the (i) Majority Independent Board Standard as set forth in Nasdaq Listing Rule 5605(b)(1) and (ii) Audit Committee Composition Standard as set forth in Nasdaq Listing Rule 5605(c)(2)(A). The Company is in the process of reviewing and evaluating potential options to regain compliance with these continued listing requirements noted above in a manner consistent with the cure peri
View on SEC.gov

Browse all listing & compliance notices →

WINDTREE THERAPEUTICS INC /DE/ filing history →

Source: SEC EDGAR
accession 0001437749-24-036752
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.